Oral fludarabine: a viewpoint by Dieter Huhn

Drugs. 2003;63(21):2324. doi: 10.2165/00003495-200363210-00005.
No abstract available

Publication types

  • Comment

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacokinetics
  • Biological Availability
  • Clinical Trials as Topic
  • Humans
  • Injections, Intravenous
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Vidarabine / administration & dosage*
  • Vidarabine / adverse effects
  • Vidarabine / analogs & derivatives*
  • Vidarabine / pharmacokinetics

Substances

  • Antineoplastic Agents
  • Vidarabine
  • fludarabine